div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imageimg data-url=patient-sous-la-forme-de-mthyl-prednisolone-medrol-la-dose-initiale-dehtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: pathologyjhuedupathologyjhueduhypophysitispdf682_2010_Lebbepdfpatient sous la forme de méthyl-prednisolone Medrol@ à la dose initiale de 32 mgjour diminuée ensuite loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsfrreader030viewer20220405045e316041f6f1eb15c2780f08html5thumbnails1jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imageimg data-url=patient-sous-la-forme-de-mthyl-prednisolone-medrol-la-dose-initiale-dehtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: pathologyjhuedupathologyjhueduhypophysitispdf682_2010_Lebbepdfpatient sous la forme de méthyl-prednisolone Medrol@ à la dose initiale de 32 mgjour diminuée ensuite loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsfrreader030viewer20220405045e316041f6f1eb15c2780f08html5thumbnails2jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imageimg data-url=patient-sous-la-forme-de-mthyl-prednisolone-medrol-la-dose-initiale-dehtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: pathologyjhuedupathologyjhueduhypophysitispdf682_2010_Lebbepdfpatient sous la forme de méthyl-prednisolone Medrol@ à la dose initiale de 32 mgjour diminuée ensuite loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsfrreader030viewer20220405045e316041f6f1eb15c2780f08html5thumbnails3jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imageimg data-url=patient-sous-la-forme-de-mthyl-prednisolone-medrol-la-dose-initiale-dehtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: pathologyjhuedupathologyjhueduhypophysitispdf682_2010_Lebbepdfpatient sous la forme de méthyl-prednisolone Medrol@ à la dose initiale de 32 mgjour diminuée ensuite loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsfrreader030viewer20220405045e316041f6f1eb15c2780f08html5thumbnails4jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imageimg data-url=patient-sous-la-forme-de-mthyl-prednisolone-medrol-la-dose-initiale-dehtmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: pathologyjhuedupathologyjhueduhypophysitispdf682_2010_Lebbepdfpatient sous la forme de méthyl-prednisolone Medrol@ à la dose initiale de 32 mgjour diminuée ensuite loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsfrreader030viewer20220405045e316041f6f1eb15c2780f08html5thumbnails5jpg width=140 height=200 divdiv